Impact of Genetic Changes on Newcastle Disease Vaccine Effectiveness
Author Information
Author(s): Gu Min, Liu Wujie, Xu Lijun, Cao Yongzhong, Yao Chunfeng, Hu Shunlin, Liu Xiufan
Primary Institution: Animal Infectious Disease Laboratory, School of Veterinary Medicine, Yangzhou University, Yangzhou, PR China
Hypothesis
The study investigates how positive selection in the hemagglutinin-neuraminidase gene of Newcastle disease virus affects vaccine efficacy.
Conclusion
The study found that the selected genetic changes in the HN protein can influence vaccine effectiveness, suggesting the need for new vaccines to combat current outbreaks.
Supporting Evidence
- Three codons in the HN protein were identified as being under positive selection.
- The recombinant fowlpox virus expressing the HN protein from a field isolate provided better immunity than the vaccine strain.
- The study suggests that new vaccines should be developed to address the evolving strains of Newcastle disease virus.
Takeaway
The researchers looked at how changes in a virus's genes can make vaccines less effective, and they found that new vaccines might be needed to fight the disease better.
Methodology
The study analyzed 132 complete HN gene sequences and conducted animal experiments with recombinant fowlpox viruses expressing different HN proteins.
Limitations
The study primarily focused on specific codons and may not account for all genetic variations affecting vaccine efficacy.
Participant Demographics
SPF chickens, 18 in each vaccinated group.
Statistical Information
P-Value
p<0.01
Statistical Significance
p<0.01
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website